Isolates were molecularly identified and initially examined to investigate their probiotic capability. The secreted metabolites of probiotic-characterized isolates were screened on different human cancer cell lines (i.e., HT29, MCF-7, AGS, and HeLa) and normal cell lines (i.e., HUVEC) to assay their anti-proliferative or cytotoxic effects.